VTGN

3.55

1.93% -0.07

Handel nachbörslich: 3.55

Vistagen Therapeutics Inc (VTGN)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$3.62

Offen:

$3.63

24-Stunden-Volumen:

273.21K

Relative Volume:

0.66

Marktkapitalisierung:

$108.92M

Einnahmen:

$875.70K

Nettoeinkommen (Verlust:

$-39.57M

KGV:

-2.6447

EPS:

-1.3423

Netto-Cashflow:

$-33.65M

1W Leistung:

+6.29%

1M Leistung:

+21.58%

6M Leistung:

+31.48%

1J Leistung:

+8.90%

1-Tages-Spanne:

$3.52

$3.6965

1-Wochen-Bereich:

$3.34

$3.88

52-Wochen-Spanne:

$1.90

$3.88

Vistagen Therapeutics Inc Stock (VTGN) Company Profile

Firmenname

Vistagen Therapeutics Inc

Sektor

Healthcare (1149)

Branche

Biotechnology (644)

Telefon

650-577-3600

Adresse

343 ALLERTON AVENUE, SOUTH SAN FRANCISCO

Mitarbeiter

Twitter

@vistagen

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

VTGN's Discussions on Twitter

Vergleichen Sie VTGN mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
VTGN Vistagen Therapeutics Inc	3.55	111.06M	875.70K	-39.57M	-33.65M	-1.3423
VRTX Vertex Pharmaceuticals Inc	396.12	101.77B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	573.38	60.12B	14.21B	4.46B	3.56B	39.68
ALNY Alnylam Pharmaceuticals Inc	452.00	59.45B	2.46B	-319.09M	-52.09M	-2.47
ARGX Argen X Se Adr	750.78	44.90B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	341.80	35.07B	3.81B	-644.79M	-669.77M	-6.24

Vistagen Therapeutics Inc Stock (VTGN) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-12-07	Hochstufung	Jefferies	Hold → Buy
2023-08-07	Hochstufung	Maxim Group	Hold → Buy
2022-07-22	Herabstufung	Jefferies	Buy → Hold
2022-07-22	Herabstufung	Robert W. Baird	Outperform → Neutral
2022-07-22	Herabstufung	William Blair	Outperform → Mkt Perform
2021-05-20	Eingeleitet	Robert W. Baird	Outperform
2021-02-18	Eingeleitet	Jefferies	Buy
2021-01-04	Hochstufung	William Blair	Mkt Perform → Outperform
2018-06-27	Eingeleitet	Maxim Group	Buy
2018-02-08	Bestätigt	Chardan Capital Markets	Buy
2017-03-28	Eingeleitet	Maxim Group	Buy

Alle ansehen

Vistagen Therapeutics Inc Aktie (VTGN) Neueste Nachrichten

08:54 AM

ADAR1 Capital Management LLC Buys 299,304 Shares of VistaGen Therapeutics, Inc. $VTGN - MarketBeat

08:54 AM

05:13 AM

Can Vistagen Therapeutics Inc. rally from current levelsWeekly Profit Report & Proven Capital Preservation Methods - Newser

05:13 AM

Sep 05, 2025

Using AI based signals to follow Vistagen Therapeutics Inc.2025 Fundamental Recap & Weekly High Momentum Picks - Newser

Sep 05, 2025

Price momentum metrics for Vistagen Therapeutics Inc. explainedPortfolio Growth Summary & Weekly Chart Analysis and Trade Guides - Newser

Sep 05, 2025

Real time social sentiment graph for Vistagen Therapeutics Inc.July 2025 News Drivers & Technical Analysis for Trade Confirmation - Newser

Sep 05, 2025

Is Vistagen Therapeutics Inc. stock undervalued right nowJuly 2025 Short Interest & Growth Oriented Trading Recommendations - خودرو بانک

Sep 05, 2025

Sep 04, 2025

Is this a good reentry point in Vistagen Therapeutics Inc.Portfolio Performance Report & AI Enhanced Trade Execution Alerts - Newser

Sep 04, 2025

How to build a custom watchlist for Vistagen Therapeutics Inc.July 2025 Retail & Risk Adjusted Swing Trade Ideas - Newser

Sep 04, 2025

Vistagen Therapeutics Inc. stock retracement – recovery analysis2025 Key Highlights & Weekly High Return Stock Opportunities - Newser

Sep 04, 2025

Earnings visualization tools for Vistagen Therapeutics Inc.Stop Loss & Fast Gain Stock Trading Tips - Newser

Sep 04, 2025

How to monitor Vistagen Therapeutics Inc. with trend dashboardsMarket Growth Review & Growth-Oriented Investment Plans - Newser

Sep 04, 2025

Can trapped investors hope for a rebound in Vistagen Therapeutics Inc.July 2025 Movers & Expert Approved Momentum Ideas - Newser

Sep 04, 2025

Sep 03, 2025

Technical analysis overview for Vistagen Therapeutics Inc. stockEarnings Risk Report & AI Enhanced Trading Alerts - Newser

Sep 03, 2025

Vistagen Therapeutics Inc. stock outlook for YEARJuly 2025 PreEarnings & Growth-Oriented Investment Plans - Newser

Sep 03, 2025

Measuring Vistagen Therapeutics Inc.’s beta against major indicesWeekly Investment Recap & Free AI Powered Buy and Sell Recommendations - Newser

Sep 03, 2025

Is Vistagen Therapeutics Inc. forming a bullish divergenceJobs Report & Capital Efficient Trade Techniques - khodrobank.com

Sep 03, 2025

Tick level data insight on Vistagen Therapeutics Inc. volatilityCEO Change & Free High Return Stock Watch Alerts - Newser

Sep 03, 2025

Vistagen Therapeutics Inc. stock chart pattern explainedIPO Watch & Weekly High Return Stock Opportunities - Newser

Sep 03, 2025

Is Vistagen Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 Action & High Accuracy Swing Entry Alerts - Newser

Sep 03, 2025

Why is Vistagen Therapeutics Inc. stock going down2025 Growth vs Value & Accurate Buy Signal Notifications - خودرو بانک

Sep 03, 2025

What to do if you’re stuck in Vistagen Therapeutics Inc.Earnings Growth Summary & Weekly Market Pulse Updates - Newser

Sep 03, 2025

Should you buy the dip on Vistagen Therapeutics Inc.2025 Analyst Calls & Fast Gaining Stock Strategy Reports - خودرو بانک

Sep 03, 2025

Sep 02, 2025

Is Vistagen Therapeutics Inc.’s growth already priced inJuly 2025 Patterns & Low Risk High Win Rate Stock Picks - خودرو بانک

Sep 02, 2025

Using flow based indicators on Vistagen Therapeutics Inc.2025 Support & Resistance & Risk Controlled Swing Alerts - Newser

Sep 02, 2025

VistaGen Bets On Nasal Therapies For Anxiety And Depression - Finimize

Sep 02, 2025

Is Vistagen Therapeutics Inc. a top pick in the sectorJuly 2025 Drop Watch & Smart Investment Allocation Insights - خودرو بانک

Sep 02, 2025

Published on: 2025-09-02 16:30:46 - خودرو بانک

Sep 02, 2025